Information on the target
Maash, a Belgian company, is at the forefront of a food innovation revolution, specializing in the production of LoCylia®, a mycoprotein derived from fermentation. This product is designed to seamlessly integrate into industrial recipes, serving as a complement or replacement for both animal and plant proteins, all without the use of chemical additives. With a cost structure that is equivalent to or lower than traditional alternatives, LoCylia® boasts a higher protein content, a more comprehensive nutritional profile, and an environmental impact that is 90% lower than that of animal proteins.
The company has strategically acquired an industrial fermentation facility in France for €1.8 million, a significant reduction from its original construction cost of €70 million in 2020. This acquisition not only provides Maash with a competitive edge but also establishes a structural barrier to entry in the market. The co-founder, Frédéric Van Gansberghe, brings extensive experience, having previously built 12 fermentation plants globally and being instrumental in the success of two industry leaders, Galactic and Futerro.
Industry overview in the target’s specific country
The European market for mycoproteins is projected to exceed 4 million tons by 2025, with an annual growth rate of 12% since 2020. This growth is driven by increasing consumer demand for sustainable and alternative protein sources, as well as a growing awareness of the environmental impact of traditional animal farming. The fermentation technology utilized by Maash positions it well within this expanding market, as it offers a viable solution to meet the rising protein needs of the population while minimizing ecological footprints.
Furthermore, the current geopolitical tensions and supply chain disruptions have heightened the urgency for alternative protein sources. As traditional supply chains face challenges, companies like Maash are poised to capitalize on the shift towards more resilient and sustainable food production methods. The favorable regulatory environment in Europe, which increasingly supports innovation in food technology, further enhances the prospects for growth in this sector.
In addition to market dynamics, consumer preferences are shifting towards health-conscious and environmentally friendly products. This trend is reflected in the increasing acceptance of fermentation-derived proteins, which are perceived as healthier and more sustainable alternatives. As consumers become more educated about food sources, the demand for products like LoCylia® is expected to rise, creating a robust market opportunity for Maash.
The rationale behind the deal The acquisition of the fermentation facility represents a strategic move for Maash, allowing the company to scale its production capabilities rapidly and efficiently. This operational advantage, combined with the growing market demand fo…